ArticleCancer chemotherapy and pharmacology2026
Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
Peng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.